BICO (HUREL CORP.)
Company Snapshot
Founded: 2016
Entity Type: Public
Employees: 711
Region: U.S.
Revenue: $184.1 Millions
Revenue Year: 2024
Headquarter: Goteborg, Sweden
Key Geographics: North America, Europe, Asia-Pacific, Other Countries
Company Overview
BICO specializes in advancing and commercializing bioprinting technologies, facilitating the printing of three-dimensional (3D) human organs and tissues for research purposes. Their product range includes bioprinters, drug screening tools, dispensing solutions, automated non-contact plate washers and liquid dispensers. Additionally, they offer pheromone, a platform for sorting and dispensing single large particles. BICO serves a diverse clientele, including research institutions and pharmaceutical, biopharmaceutical, automotive, and cosmetic companies.
Cellink and MatTek are the subsidiaries of BICO.
Financial Highlights (FY 2023)
Net Revenue: ***
Total Current Liabilities: ***
Total Current Assets: ***
R&D expenses: ***
Operating Income: ***
This information is available for BCC Research members only.
Applications/End User Industries
- Lab Automation
- Life Science Solutions
- Bioprinting